BIOLASE, Inc. announced that it has appointed veteran senior dental industry executive, Todd A. Norbe and veteran senior finance executive Jess Roper to its Board of Directors, effective immediately. Mr. Roper will become chairman of the audit committee and replace James R. Talevich, who resigned from the Board due to other commitments. The addition of Mr. Norbe increases the size of the Board to five directors. Mr. Norbe, 51, was most recently the President, North America of KaVo Kerr, a subsidiary of the Danaher Corporation, where he held executive leadership positions from 2006 to 2018. Mr. Roper, 53, has considerable financial and audit experience in the sectors of medical devices, life sciences, technology, manufacturing, and financial institutions. He joined San Diego-based Dexcom, Inc., in 2005 and he most recently served as its Senior Vice President and Chief Financial Officer, retiring in April 2017.